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There are many causes of prolonged postoperative muscle weakness, including drugs, residual anesthetics, 
cerebrovascular events, electrolyte imbalance, hypothermia, and neuromuscular disease.  Neuromuscular diseases 
are relatively rare, with the most common being myasthenia gravis and Lambert-Eaton myasthenic syndrome (LEMS).   
We report an unusual case in which a patient who was given a muscle relaxant during mediastinoscopy developed 
postoperative muscle weakness that was ultimately diagnosed as secondary to LEMS.  (Korean J Anesthesiol 2010; 59: 
45-48)
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    In the clinical setting, postoperative muscle weakness is 
usually attributed to residual anesthetic effects or prolonged 
neuromuscular blockade. The differential diagnosis of 
postoperative muscle weakness includes residual anesthetic, 
cerebrovascular events, electrolyte imbalance, hypothermia, 
and neuromuscular disease. Musculoskeletal disorders are 
relatively rare, with the most common being myasthenia gravis 
and Lambert-Eaton myasthenic syndrome (LEMS) [1,2].
    LEMS is a rare neuromuscular junction disease [1]. The 
clinical features described by Rooke et al. [3] and O'Neill et al. 
[4] are proximal weakness, especially in the lower limbs, with 
diminished tendon reflexes and post-tetanic potentiation. 
Autonomic symptoms are often reported, including pupil 
abnormalities, dry eyes and mouth, and erectile dysfunction 
[5]. Often, the signs and symptoms of LEMS are mistaken for 
myasthenia gravis and therefore the workup is misdirected [1].
    We present a rare case of postoperative prolonged neuro-
muscular weakness in a previously asymptomatic patient. He 
was subsequently diagnosed with LEMS.
Case Report
    A 72-year-old man, 169 cm tall and weighing 56 kg, com-
plained of general weakness and the diagnostic workup 46 www.ekja.org
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suggested lung cancer with mediastinal lymphadenopathy 
and syndrome of inappropriate secretion of anti-diuretic 
hormone (SIADH). To obtain a tissue diagnosis, the patient was 
scheduled for a mediastinoscopic biopsy.
    He had smoked two packs of cigarettes a day for 55 years and 
had drunk one-and-a-half bottles of soju a day for 50 years. 
There was no history of neuromuscular disorders and no family 
history of neuromuscular disease. Four years earlier, he had 
complained of vertigo and gait disturbance for 1 month and a 
neurologist had suspected of encephalitis.
    Preoperatively, the routine laboratory values were within 
normal limits, except for hyponatremia (125 mEq/L). He had no 
symptoms or signs of hyponatremia, such as nausea, vomiting, 
visual disturbances, depressed level of consciousness, agitation, 
confusion, muscle cramps, weakness, etc. After a nephrology 
consultation, we decided to perform the scheduled biopsy 
based on the absence of symptoms and signs associated with 
hyponatremia and the need to obtain a tissue biopsy to decide 
on treatment. Pulmonary function tests showed small airway 
disease.
    In the operating room, routine monitoring was used, although 
neuromuscular transmissions were not monitored. General 
anesthesia was induced with propofol and succinylcholine. 
After tracheal intubation, anesthesia was maintained with 
inhaled sevoflurane 1.5-3 vol% and 50% nitrous oxide in 
oxygen. Intravenous vecuronium 4 mg was administered for 
muscle relaxation. Perioperative fluid administration was 
restricted due to the SIADH. The biopsy was obtained and the 
pathology showed small cell carcinoma of the lung. It took 
about 1 hour to incision closure from the time vecuronium was 
given.
    At the end of the procedure, intravenous glycopyrrolate 0.4 
mg and pyridostigmine 15 mg were administered to reverse 
the blockade, but the patient remained motionless and 
could not breathe spontaneously 40 minutes after reversal. 
Therefore, we administered atropine 0.5 mg and neostigmine 
1.0 mg intravenously in case the dose of the reversal agent 
had been inadequate. However, there was no improvement in 
neuromuscular function. His pupils were equal and reactive. 
The oral body temperature was 36.2
oC and no antibiotics known 
to cause neuromuscular blockade had been administered.
    We monitored neuromuscular function by attaching a nerve 
stimulator (TOF-Watch
Ⓡ, Organon Ireland Ltd., Dublin, Ireland). 
There was no twitch response to TOF stimulation, although 
there was a very weak response to tetanic stimulation at 50 
Hz for 5 seconds with no post-tetanic potentiation. A blood 
sample was drawn to check the serum electrolytes. There were 
no abnormal values, other than a serum sodium that was 
lower than the preoperative level. We thought that sympathetic 
activation due to the operation might have led to significantly 
increased levels of ADH in the absence of volume constriction. 
We began to correct the hyponatremia with 3% hypertonic 
saline, slowly, to prevent cerebral edema or central pontine 
myelinolysis.
    About 2 hours after the end of the procedure, he began to 
move his fingers slightly and there were four twitch responses to 
TOF stimulation. However, there was no voluntary respiratory 
movement or eye opening. We believed that he was alert 
because he could move his fingers in response to verbal 
commands.
    He was taken to the postanesthesia care unit and placed on a 
mechanical ventilator. With time, his hyponatremia improved 
slowly to within the normal range and his neuromuscular 
function improved. He could move his forearm and hands, but 
lacked sufficient muscle strength to breathe spontaneously 
and be extubated. We began to suspect a neuromuscular 
transmission disorder and a consultation with a neurologist 
established the diagnosis of LEMS by electromyography (Fig. 1). 
He was given anticholinesterase via a nasogastric tube, but there 
was no improvement in neuromuscular function. Two weeks 
postoperatively, all the laboratory values were within normal 
limits. He could sit up and write letters. However, weaning from 
the mechanical ventilator was impossible. He was discharged 
with a portable ventilator.
Discussion
    We described a patient with LEMS who presented with 
inadequate recovery from muscular blockade and could not 
be extubated after a mediastinoscopic biopsy. We suspected 
hyponatremia as the cause of the prolonged muscular 
weakness. However, inadequate neuromuscular recovery 
persisted after correcting the hyponatremia. In this case, 
we could not find other causes of inadequate recovery from 
muscular blockade. After a neurology consultation, he was 
diagnosed as LEMS.
    LEMS is an autoimmune presynaptic disorder of neuro-
muscular transmission [5]. Immunoglobulin G auto-antibodies 
attack the prejunctional voltage-gated calcium channels and 
a paucity of prejunctional calcium causes decreased release of 
acetylcholine quanta into the neuromuscular cleft, resulting in 
skeletal muscle weakness [4,6]. The proximal lower extremity 
muscles tend to be more susceptible than those in the upper 
extremity [4,6,7]. Skeletal muscle strength often improves 
with repetitive movement or exercise as more quanta of 
acetylcholine are released into the neuromuscular junction, but 
is unresponsive to anticholinesterase medications [4,7]. Other 
symptoms include hypo- or areflexia, autonomic dysfunction 
(impotence, xerostomia, impaired sweating, etc.), and 
occasionally bulbar dysfunction [4,7,8].47 www.ekja.org
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    LEMS more commonly affects individuals over 40 years of 
age and has a male predominance; additionally, the symptoms 
usually precede tumor diagnosis by over 10 months [4,7].
    The diagnosis is confirmed by demonstrating the characteristic 
electromyographic finding, which is an abnormally low 
amplitude of the compound muscle action potential evoked 
by a single nerve stimulus in rested muscle and a progressive 
increase during high-frequency stimulation or immediately 
after brief maximal voluntary contraction of the muscle. Our 
patient had the typical electrophysiologic abnormality (Fig. 1). 
The diagnosis of LEMS can also be established by the presence 
of voltage-gated calcium channel antibodies. However, we 
decided not to check the antibodies because of cost and 
accessibility problems.
    Many reports have associated LEMS with intrathoracic 
tumors, most notably small cell lung cancer. Our patient also 
had small cell carcinoma of the lung. Tumors associated with 
this syndrome include bronchogenic small cell carcinoma 
Fig. 1. Repetitive stimulation of the ulnar nerve at low and higher rates. Trial 2 is single post-exercise stimulation that shows a marked 
incremental response compared with a single stimulation (trial 1). Repetitive stimulation of the ulnar nerve at low rates (Trials 3 to 5 at 2, 3, and 
5 Hz, respectively) produced a decremental response in the amplitude of the compound muscle action potentials (CMAPs) recorded from the 
left abductor digiti minimi muscle. By contrast, stimulation at higher rates (Trial 6; 50 Hz) definitely produced an incremental response in the 
amplitude of the CMAP.48 www.ekja.org
Lambert-Eaton myasthenic syndrome Vol. 59, No. 1, July 2010
and breast, ovarian, prostate, and gastrointestinal cancer [4,6-
8]. LEMS should trigger an intensive search for malignancy, 
especially in patients with a history of tobacco use/abuse [9]. 
Nevertheless, nearly half of LEMS cases occur in the absence of 
malignancy [4,7].
    The treatment options for LEMS include corticosteroids 
and immunosuppressive drugs, usually with positive clinical 
out  comes [10]. Immunosuppressants do have a role in the 
treatment of LEMS without malignancy [1]. However, when 
compared to myasthenia gravis, the response to immuno-
suppres  sion is considerably slower [10]. Since LEMS is mediated 
by circulating autoantibodies, it is a good candidate for immu-
no  modulation by intravenous immunoglobulins. But, there 
are no standardized controlled studies [10]. Guanidine hydro-
chloride inhibits calcium uptake into subcellular organelles, 
resulting in increased intracellular calcium, which facilitates 
acetylcholine release from the nerve terminal [7]. However, 
the side effects of this drug detract from its clinical usefulness. 
3,4-diaminopyridine is a drug that selectively blocks potassium 
in these channels, preventing potassium efflux and prolonging 
the action potential [7]. This prolongation leaves the voltage-
gated calcium channel open longer, which results in more 
calcium entry and more acetylcholine release [7]. In most 
patients with LEMS, 3,4-diaminopyridine will improve strength 
[1]. However, 3,4-diaminopyridine was not available at our 
hospital. Sometimes, LEMS can be combined with myasthenia 
gravis (overlap myasthenic syndrome) and one patient with this 
combination responded favorably to treatment with prednisone 
and anticholinesterase agents [11]. Therefore, we gave our 
patient anticholinesterase, but there was no improvement in his 
neuromuscular functions. The possibility of anticholinesterase 
overload, which could lead to delayed neuromuscular recovery, 
could be ruled out because there were no symptoms or signs 
of muscarinic effects of anticholinesterase, such as nausea, 
vomiting, salivation, diarrhea, and bradycardia [12].
    Patients with LEMS have increased sensitivity to both 
depolarizing and non-depolarizing muscle relaxants; however, 
the duration of block prolongation is unknown [3,4,7]. 
Therefore, one must be careful with the use of depolarizing or 
nondepolarizing muscle relaxants perioperatively.
    Patients with LEMS have varying degrees of postoperative 
neuromuscular recovery. One patient was given succinylcholine 
as part of anesthesia and was extubated postoperatively; 
two days postoperatively, he developed respiratory failure 
and required mechanical ventilation [13]. Another patient 
given suxamethonium and D-tubocurarine could not be 
extu  bated for about 7 hours [14]. Yet another patient, who 
under  went a thyroidectomy under general anesthesia with 
vecuronium, required mechanical ventilation for about 16 
hours postoperatively [2]. And another patient was extubated 
uneventfully about 3 hours after a cisatracurium bolus [15].
    Although LEMS is a rare neuromuscular junction disease, 
it should be considered as one of the causes of inadequate 
neuromuscular recovery postoperatively, especially in patients 
with small cell lung cancer. Monitoring neuromuscular function 
in the operative period is essential for evaluating the differential 
diagnosis of inadequate recovery from neuromuscular blockade.
References
1.   Weimer MB, Wong J. Lambert-Eaton myasthenic syndrome. Curr 
Treat Options Neurol 2009; 11: 77-84.
2. Bui PK, Kuczkowski KM, Moeller-Bertram T, Sanchez RA. New onset 
Lambert-Eaton myasthenic syndrome as an unexpected cause of 
delayed recovery from general anesthesia after thyroidectomy. Ann 
Fr Anesth Reanim 2004; 23: 926-7.
3. Rooke ED, Eaton LM, Lambert EH, Hodgson CH. Myasthenia and 
malignant intrathoracic tumor. Med Clin North Am 1960; 44: 977-
88.
4. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton 
myasthenic syndrome. A review of 50 cases. Brain 1988; 111: 577-
96.
5. Maddison P, Newsom-Davis J. Treatment for Lambert-Eaton 
myasthenic syndrome. Cochrane Database Syst Rev 2003; 2: 
CD003279.
6. Greenberg DA. Calcium channels in neurological disease. Ann 
Neurol 1997; 42: 275-82.
7. Sanders DB. Lambert-Eaton myasthenic syndrome: clinical 
diagnosis, immune-mediated mechanisms, and update on 
therapies. Ann Neurol 1995; 37(Suppl 1): S63-73.
8. Blumenfeld AM, Recht LD, Chad DA, DeGirolami U, Griffin T, 
Jaeckle KA. Coexistence of Lambert-Eaton myasthenic syndrome 
and subacute cerebellar degeneration: differential effects of 
treatment. Neurology 1991; 41: 1682-5.
9. Brueck M, Vogel S, Waeger S, Braig G, Kramer W. Lambert-Eaton 
myasthenic syndrome with acute respiratory failure associated with 
small cell lung cancer. Dtsch Med Wochenschr 2004; 129: 193-6.
10. Antozzi C. Myasthenia gravis and myasthenic syndrome. Neurol Sci 
2003; 24(Suppl 4): S260-3.
11. Roohi F, Smith PR, Bergman M, Baig MA, Sclar G. A diagnostic and 
management dilemma: combined paraneoplastic myasthenia 
gravis and Lambert-Eaton myasthenic syndrome presenting as 
acute respiratory failure. Neurologist 2006; 12: 322-6.
12. Hetherington KA, Losek JD. Myasthenia gravis: myasthenia vs. 
cholinergic crisis. Pediatr Emerg Care 2005; 21: 546-8.
13. Gracey DR, Southorn PA. Respiratory failure in Lambert-Eaton 
myasthenic syndrome. Chest 1987; 91: 716-8.
14. Macdonell RA, Rich JM, Cros D, Shahani BT, Ali HH. The Lambert-
Eaton myasthenic syndrome: a cause of delayed recovery from 
general anesthesia. Arch Phys Med Rehabil 1992; 73: 98-100.
15. Leonovicz BM, Gordon EA, Wass CT. Paraneoplastic syndromes 
associated with lung cancer: a unique case of concomitant 
subacute cerebellar degeneration and Lambert-Eaton myasthenic 
syndrome. Anesth Analg 2001; 93: 1557-9.